SCHEMBL9759904

SCHEMBL9759904

CNC(=O)c1cc(C(=O)c2ccccc2)ccc1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 6/20 0.55
HDAC1 Q13547 6/20 0.55
MAPT P10636 5/20 0.55
HDAC3 O15379 5/20 0.55
HDAC4 P56524 5/20 0.55
HDAC7 Q8WUI4 5/20 0.55
HDAC2 Q92769 5/20 0.55
HDAC10 Q969S8 5/20 0.55
HDAC11 Q96DB2 5/20 0.55
HDAC8 Q9BY41 5/20 0.55
HDAC6 Q9UBN7 5/20 0.55
HDAC9 Q9UKV0 5/20 0.55
HDAC5 Q9UQL6 5/20 0.55
POLB P06746 2/20 0.55
GAA P10253 1/20 0.54
MAPK1 P28482 3/20 0.50
PBRM1 Q86U86 1/20 0.49
HTT P42858 2/20 0.48
LMNA P02545 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30871249 0.83 HDAC1 (0.52) BRAFHDAC1HDAC3HDAC4HDAC7
SCHEMBL28366217 0.82 MAPT (0.56) MAPTPOLBGAAMAPK1PBRM1
SCHEMBL27549798 0.82 POLB (0.59) MAPTPOLBGAAMAPK1PBRM1
SCHEMBL6981967 0.81 GAA (0.57) HDAC1HDAC8HDAC6GAANPC1
SCHEMBL9196519 0.80 IKBKB (0.59) MAPTPOLBGAAMAPK1PBRM1
SCHEMBL7608088 0.80 MAPT (0.62) MAPTHDAC2POLBGAAMAPK1
SCHEMBL9760868 0.80 MAPK1 (0.59) MAPTPOLBGAAMAPK1TDP1
SCHEMBL11357069 0.77 RAB9A (0.62) HDAC1HDAC3HDAC7HDAC2HDAC8
SCHEMBL11504870 0.76 AKR1C3 (0.63) MAPTPOLBGAAATMTDP1
SCHEMBL30874183 0.76 PBRM1 (0.62) MAPTPOLBGAAMAPK1PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1036002-C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 1997-10-01 CN disclosed
CN-1033752-C (1H-azol-1-ylmethyl) substituted quinoline or quinolinone derivatives JANSSEN PHARMACEUTICA NV (SE) 1997-01-08 CN disclosed
CN-1106005-A A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
CN-1106004-A A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
US-5037829-A Antitumor Activity; Androgen, Estrogen Inhibitors; Suppress The Plasma Elimination Of Retinoids JANSSEN PHARMACEUTICA N.V. (BE) 1991-08-06 US disclosed
CN-1042912-A (1H-oxazol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1990-06-13 CN disclosed